MedeliX
Start asking

Ramipril

Lannapril, Ramipril, Tritace · ATC code C09AA05

Brand names: Lannapril, Tritace, Delix, Ramilich, Corvix, Dicef, Genprixa, Race, Rapalix, Revil, Sandace

Key facts
Active substance
Ramipril
Drug class
ACE inhibitor
ATC code
C09AA05
Authorisation
authorised nationally; no central EU authorisation
Information as of
2026-10-27

Boxed warning

  • When pregnancy is detected, discontinue ramipril as soon as possible (5.6).
  • Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus (5.6).

Key facts

Ramipril is an ACE inhibitor indicated, per the US prescribing information, for hypertension, cardiovascular risk reduction and heart failure after myocardial infarction.

What it is used for

  • Hypertension, alone or with thiazide diuretics
  • Reduction in the risk of myocardial infarction, stroke and cardiovascular death in patients 55 years or older at high cardiovascular risk
  • Stable patients with signs of congestive heart failure in the first days after acute myocardial infarction

Dosing

  • Hypertension (no diuretic): start 2.5 mg once a day; maintenance 2.5 mg to 20 mg per day as one or two doses
  • Risk reduction: 2.5 mg once daily for 1 week, 5 mg for the next 3 weeks, then up to 10 mg once daily
  • Heart failure post-MI: start 2.5 mg twice daily, target 5 mg twice daily; 1.25 mg twice daily if hypotensive
  • Renal impairment (creatinine clearance ≤ 40 mL/min) and prior diuretics: lower starting dose (details in full text)
  • Swallow capsules whole or sprinkle contents on applesauce or mix in water or apple juice

Contraindications

  • Hypersensitivity to ramipril or any other ACE inhibitor (e.g. prior angioedema)
  • Combination with a neprilysin inhibitor (e.g. sacubitril); 36 hours apart
  • Aliskiren in patients with diabetes

Important warnings

  • Boxed warning: fetal toxicity; discontinue as soon as possible when pregnancy is detected
  • Angioedema (including intestinal), potentially fatal with laryngeal involvement; higher risk with mTOR or neprilysin inhibitors
  • Hypotension, impaired renal function, hyperkalemia
  • Persistent nonproductive cough

Side effects

  • Most frequent in trials: headache, dizziness, fatigue or asthenia; generally mild and transient
  • Most common reasons for discontinuation: cough, dizziness, impotence

Interactions

  • Diuretics: excessive blood pressure drop at initiation possible
  • Potassium-raising drugs: hyperkalemia; monitor potassium
  • Lithium: increased levels and toxicity; NSAIDs: deterioration of renal function
  • Injectable gold: rare nitritoid reactions; avoid combined RAS inhibitors

Pregnancy and breastfeeding

  • Use in the second and third trimesters harms the fetus; discontinue as soon as possible when pregnancy is detected

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Patient information (US)

This product has no separate US patient information.

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

Austria

  • LannaprilG.L. Pharma Gmbh · 1 register entry
  • Ramipril1a Pharma Gmbh, Teva B.V, Genericon Pharma Gesellschaft M.B.H., Actavis Group Ptc Ehf., Sandoz Gmbh, Hexal Pharma Gmbh, G.L. Pharma Gmbh, Krka, D.D., Novo Mesto · 8 register entries
  • TritaceSanofi-Aventis Gmbh Osterreich · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

  • DelixSanofi-Aventis Deutschland Gmbh · 3 register entries
  • RamilichWinthrop Arzneimittel Gmbh · 1 register entry
  • Ramipril089pharm Gmbh, 1 A Pharma Gmbh, Ratiopharm Gmbh, Hennig Arzneimittel Gmbh & Co. Kg, Hexal Ag, Puren Pharma Gmbh & Co. Kg, Stadapharm Gmbh, Abz-Pharma Gmbh, Tad Pharma Gmbh, Aliud Pharma Gmbh · 11 register entries

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • CorvixSANOVEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
  • DelixSANOFİ SAĞLIK ÜRÜNLERİ LTD. ŞTİ. · 4 register entries
  • DicefABDİ İBRAHİM İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
  • GenprixaGEN İLAÇ VE SAĞLIK ÜRÜNLERİ SAN. VE TİC. A.Ş. · 3 register entries
  • RaceALİ RAİF İLAÇ SAN. A.Ş. · 3 register entries
  • RapalixTURGUT İLAÇLARI A.Ş. · 3 register entries
  • RevilNOBEL İLAÇ SAN. VE TİC. A.Ş. · 3 register entries
  • SandaceSANDOZ İLAÇ SAN. VE TİC. A.Ş. · 3 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

Brand names in 27 more European countries
Belgium
Ramipril Ab, Ramipril Eg, Ramipril Krka, Ramipril Sandoz, Tritace
Bulgaria
Cardifriend, Амприл, Вивейс, Рамимед, Рамиприл Teва, Рамихексал, Тритейс
Croatia
Ampril, Blocar, Piramil, Prilen, Ramed, Ramipril Genericon, Tritace
Cyprus
Acapril, Ramimed, Triatec
Czechia
Amprilan, Piramil, Ramil, Ramipril Actavis, Tritace
Denmark
Alarimed, Polpril, Ramipril Aurobindo, Ramipril Hexal, Ramipril Krka, Ramipril Stada, Ramipril Teva
Estonia
Ampril, Cardace, Ramicor, Ramipril Actavis
Finland
Cardace, Ramipril Hexal, Ramipril Orion, Ramipril Ratiopharm
France
Ramipril Almus, Ramipril Arrow Generiques, Ramipril Arrow Lab, Ramipril Biogaran, Ramipril Cristers, Ramipril Eg, Ramipril Evolugen, Ramipril Krka, Ramipril Sandoz, Ramipril Teva, Ramipril Viatris, Ramipril Zentiva, Ramipril Zydus France, Triatec
Greece
Piramil, Ramisyn, Triatec
Hungary
Amprilan, Hartil, Meramyl, Ramace, Ramipril, Tritace
Iceland
Ramíl
Ireland
Ramic, Ramilo, Ramipril Krka, Ramipril Teva, Ramitace, Tritace
Italy
Herzatec, Krupil, Norapril, Quark, Ramipril Abc, Ramipril Almus, Ramipril Alter, Ramipril Aurobindo, Ramipril Doc Generici, Ramipril Eg, Ramipril Git, Ramipril Hexal, Ramipril Krka, Ramipril Mylan Generics, Ramipril Pensa, Ramipril Ranbaxy Italia, Ramipril Ratiopharm, Ramipril Sandoz, Ramipril Sun, Ramipril Tecnigen, Ramipril Zentiva, Tensiram, Triatec, Unipril
Latvia
Cardace, Ramicor, Ramipril Actavis, Ramipril Tad
Lithuania
Ampril, Cardace, Ramicor, Ramipril Actavis
Luxembourg
Ramipril Eg, Tritace
Malta
Ramipril Aurobindo, Ramipril Tad
Netherlands
Ramipril Accord, Ramipril Aurobindo, Ramipril Brillpharma, Ramipril Krka, Ramipril Mylan, Ramipril Sandoz
Norway
Ramipril Actavis, Ramipril Hexal, Triatec
Poland
Ampril, Aporami, Awerpil, Axtil, Piramil, Polpril, Ramicor, Ramipril Genoptim, Ramipril Krka, Ramve, Tritace, Vivace
Portugal
Ramipril Alter, Ramipril Aurovitas, Ramipril Azevedos, Ramipril Blixie, Ramipril Bluepharma, Ramipril Farmoz, Ramipril Generis, Ramipril Gp, Ramipril Krka, Ramipril Ratiopharm, Ramipril Ripzen, Ramipril Sandoz, Ramipril Tolife, Ramipril Zentiva, Romace, Triatec
Romania
Ampril, Ramipril Ac, Ramipril Atb, Tritace, Vivace, Zenra
Slovakia
Ampril, Piramil, Ramimed, Ramipril Actavis, Tritace
Slovenia
Ampril, Piramil, Ramipril Krka
Spain
Acovil, Ramipril Alter Genéricos, Ramipril Aristo, Ramipril Aurovitas, Ramipril Cinfa, Ramipril Cinfamed, Ramipril Krka, Ramipril Normon, Ramipril Ratiopharm, Ramipril Sandoz, Ramipril Stada, Ramipril Tarbis, Ramipril Tecnigen, Ramipril Teva, Ramipril Tevagen
Sweden
Ramiliv, Ramipril Aurobindo, Ramipril Hexal, Ramipril Krka, Ramipril Stada, Ramipril Teva

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Related calculators

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. U.S. Food and Drug Administration. Ramipril (Zydus Pharmaceuticals USA Inc.) – Prescribing Information, 2026-06-05. DailyMed (NLM), 2026-10-27. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=055bb582-67cd-425a-8823-d543c14305ce
  2. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. Wikidata (CC0): ATC C09AA.

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: U.S. Food and Drug Administration (FDA), prescribing information, via DailyMed (NLM); public domain. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.